Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04803851
What this trial is testing

Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer

Who this might be right for
AnlotinibAnti-PD-1 AntibodyAdvanced Pancreatic Cancer
Peking Union Medical College Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT07240194
What this trial is testing

The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical Study

Who this might be right for
Large B-cell LymphomaTP53
The First Affiliated Hospital with Nanjing Medical University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06336954
What this trial is testing

Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 40
Testing effectiveness (Phase 2)Study completedNCT04828486
What this trial is testing

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+2 more
Mayo Clinic 14
Testing effectiveness (Phase 2)UnknownNCT04567069
What this trial is testing

Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment

Who this might be right for
Gastric Cancer
The Second Hospital of Shandong University 45
Not applicableNot Yet RecruitingNCT06504901
What this trial is testing

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)UnknownNCT04506281
What this trial is testing

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 128
Early research (Phase 1)Looking for participantsNCT07687875
What this trial is testing

Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer

Who this might be right for
Rectal Cancer Patients
Henry Smith 20
Early research (Phase 1)Study completedNCT03990233
What this trial is testing

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor, Adult
OSE Immunotherapeutics 100
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Early research (Phase 1)Study completedNCT03523572
What this trial is testing

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Who this might be right for
Breast CancerUrothelial Carcinoma
Daiichi Sankyo 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT03950271
What this trial is testing

SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Henan Cancer Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05824481
What this trial is testing

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07523737
What this trial is testing

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 43
Testing effectiveness (Phase 2)Ended earlyNCT03041181
What this trial is testing

Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Adenocarcinoma of the LungLung Cancer+1 more
Nasser Hanna, M.D. 3
Not applicableUnknownNCT04430166
What this trial is testing

PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like Carcinoma

Who this might be right for
Lymphoepithelioma-Like Carcinoma
Guangzhou University of Traditional Chinese Medicine 12
Testing effectiveness (Phase 2)Study completedNCT02798406
What this trial is testing

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Who this might be right for
Brain CancerBrain NeoplasmGlioma+8 more
DNAtrix, Inc. 49
Very early researchUnknownNCT06106152
What this trial is testing

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

Who this might be right for
Advanced Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT04301778
What this trial is testing

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Testing effectiveness (Phase 2)Looking for participantsNCT07306286
What this trial is testing

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Next Page